Global Adalimumab Biosimilar Market Professional Survey Report 2019

Publisher Name :
Date: 20-Nov-2019
No. of pages: 114
Inquire Before Buying

The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Adalimumab Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Adalimumab Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- AET BioTech

- Amgen

- Boehringer Ingelheim

- Coherus Biosciences

- Fujifilm Kyowa Kirin Biologics

- LG Life Sciences/Mochida Pharmaceutical

- Momenta Pharmaceuticals

- Oncobiologics

- Pfizer

- Samsung Bioepsis

- Sandoz

- Zydus Cadila

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Tablet

- Oral Solution

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Global Adalimumab Biosimilar Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Adalimumab Biosimilar
1.1 Definition of Adalimumab Biosimilar
1.2 Adalimumab Biosimilar Segment by Type
1.2.1 Global Adalimumab Biosimilar Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Adalimumab Biosimilar Segment by Applications
1.3.1 Global Adalimumab Biosimilar Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Overall Market
1.4.1 Global Adalimumab Biosimilar Revenue (2014-2025)
1.4.2 Global Adalimumab Biosimilar Production (2014-2025)
1.4.3 North America Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.4 Europe Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.5 China Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.6 Japan Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.7 Southeast Asia Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.8 India Adalimumab Biosimilar Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.3 Manufacturing Process Analysis of Adalimumab Biosimilar
2.4 Industry Chain Structure of Adalimumab Biosimilar
3 Development and Manufacturing Plants Analysis of Adalimumab Biosimilar
3.1 Capacity and Commercial Production Date
3.2 Global Adalimumab Biosimilar Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Adalimumab Biosimilar
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Adalimumab Biosimilar Production and Capacity Analysis
4.2 Adalimumab Biosimilar Revenue Analysis
4.3 Adalimumab Biosimilar Price Analysis
4.4 Market Concentration Degree
5 Adalimumab Biosimilar Regional Market Analysis
5.1 Adalimumab Biosimilar Production by Regions
5.1.1 Global Adalimumab Biosimilar Production by Regions
5.1.2 Global Adalimumab Biosimilar Revenue by Regions
5.2 Adalimumab Biosimilar Consumption by Regions
5.3 North America Adalimumab Biosimilar Market Analysis
5.3.1 North America Adalimumab Biosimilar Production
5.3.2 North America Adalimumab Biosimilar Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Adalimumab Biosimilar Import and Export
5.4 Europe Adalimumab Biosimilar Market Analysis
5.4.1 Europe Adalimumab Biosimilar Production
5.4.2 Europe Adalimumab Biosimilar Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Adalimumab Biosimilar Import and Export
5.5 China Adalimumab Biosimilar Market Analysis
5.5.1 China Adalimumab Biosimilar Production
5.5.2 China Adalimumab Biosimilar Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Adalimumab Biosimilar Import and Export
5.6 Japan Adalimumab Biosimilar Market Analysis
5.6.1 Japan Adalimumab Biosimilar Production
5.6.2 Japan Adalimumab Biosimilar Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Adalimumab Biosimilar Import and Export
5.7 Southeast Asia Adalimumab Biosimilar Market Analysis
5.7.1 Southeast Asia Adalimumab Biosimilar Production
5.7.2 Southeast Asia Adalimumab Biosimilar Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Adalimumab Biosimilar Import and Export
5.8 India Adalimumab Biosimilar Market Analysis
5.8.1 India Adalimumab Biosimilar Production
5.8.2 India Adalimumab Biosimilar Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Adalimumab Biosimilar Import and Export
6 Adalimumab Biosimilar Segment Market Analysis (by Type)
6.1 Global Adalimumab Biosimilar Production by Type
6.2 Global Adalimumab Biosimilar Revenue by Type
6.3 Adalimumab Biosimilar Price by Type
7 Adalimumab Biosimilar Segment Market Analysis (by Application)
7.1 Global Adalimumab Biosimilar Consumption by Application
7.2 Global Adalimumab Biosimilar Consumption Market Share by Application (2014-2019)
8 Adalimumab Biosimilar Major Manufacturers Analysis
8.1 AET BioTech
8.1.1 AET BioTech Adalimumab Biosimilar Production Sites and Area Served
8.1.2 AET BioTech Product Introduction, Application and Specification
8.1.3 AET BioTech Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Adalimumab Biosimilar Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Adalimumab Biosimilar Production Sites and Area Served
8.3.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Coherus Biosciences
8.4.1 Coherus Biosciences Adalimumab Biosimilar Production Sites and Area Served
8.4.2 Coherus Biosciences Product Introduction, Application and Specification
8.4.3 Coherus Biosciences Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Fujifilm Kyowa Kirin Biologics
8.5.1 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Sites and Area Served
8.5.2 Fujifilm Kyowa Kirin Biologics Product Introduction, Application and Specification
8.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 LG Life Sciences/Mochida Pharmaceutical
8.6.1 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Sites and Area Served
8.6.2 LG Life Sciences/Mochida Pharmaceutical Product Introduction, Application and Specification
8.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Momenta Pharmaceuticals
8.7.1 Momenta Pharmaceuticals Adalimumab Biosimilar Production Sites and Area Served
8.7.2 Momenta Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Oncobiologics
8.8.1 Oncobiologics Adalimumab Biosimilar Production Sites and Area Served
8.8.2 Oncobiologics Product Introduction, Application and Specification
8.8.3 Oncobiologics Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer
8.9.1 Pfizer Adalimumab Biosimilar Production Sites and Area Served
8.9.2 Pfizer Product Introduction, Application and Specification
8.9.3 Pfizer Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Samsung Bioepsis
8.10.1 Samsung Bioepsis Adalimumab Biosimilar Production Sites and Area Served
8.10.2 Samsung Bioepsis Product Introduction, Application and Specification
8.10.3 Samsung Bioepsis Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sandoz
8.12 Zydus Cadila
9 Development Trend of Analysis of Adalimumab Biosimilar Market
9.1 Global Adalimumab Biosimilar Market Trend Analysis
9.1.1 Global Adalimumab Biosimilar Market Size (Volume and Value) Forecast 2019-2025
9.2 Adalimumab Biosimilar Regional Market Trend
9.2.1 North America Adalimumab Biosimilar Forecast 2019-2025
9.2.2 Europe Adalimumab Biosimilar Forecast 2019-2025
9.2.3 China Adalimumab Biosimilar Forecast 2019-2025
9.2.4 Japan Adalimumab Biosimilar Forecast 2019-2025
9.2.5 Southeast Asia Adalimumab Biosimilar Forecast 2019-2025
9.2.6 India Adalimumab Biosimilar Forecast 2019-2025
9.3 Adalimumab Biosimilar Market Trend (Product Type)
9.4 Adalimumab Biosimilar Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Adalimumab Biosimilar Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Adalimumab Biosimilar
Table Global Adalimumab Biosimilar Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Adalimumab Biosimilar Production Market Share by Types in 2018
Figure Tablet Product Picture
Figure Oral Solution Product Picture
Table Global Adalimumab Biosimilar Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Adalimumab Biosimilar Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacy
Figure Online Pharmacy
Figure Global Adalimumab Biosimilar Revenue (Million USD) (2014-2025)
Figure Global Adalimumab Biosimilar Production (K Units) (2014-2025)
Figure North America Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Europe Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure China Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Japan Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Southeast Asia Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure India Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Table Adalimumab Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Adalimumab Biosimilar in 2018
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Industry Chain Structure of Adalimumab Biosimilar
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Adalimumab Biosimilar Manufacturing Plants Distribution
Table Adalimumab Biosimilar Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Adalimumab Biosimilar Capacity (K Units) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Production (K Units) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Production Market Share of Major Manufacturers (2014-2019)
Figure Adalimumab Biosimilar Production Share by Manufacturers in 2018
Table Adalimumab Biosimilar Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Revenue Market Share of Major Manufacturers (2014-2019)
Figure Adalimumab Biosimilar Revenue Share by Manufacturers in 2018
Table Adalimumab Biosimilar Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Adalimumab Biosimilar Production by Regions 2014-2019 (K Units)
Table Global Adalimumab Biosimilar Production Market Share by Regions 2014-2019
Figure Global Adalimumab Biosimilar Production Market Share by Regions in 2018
Table Global Adalimumab Biosimilar Revenue by Regions 2014-2019 (Million USD)
Table Global Adalimumab Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Adalimumab Biosimilar Revenue Market Share by Regions in 2018
Table Global Adalimumab Biosimilar Consumption by Regions 2014-2019 (K Units)
Table Global Adalimumab Biosimilar Consumption Market Share by Regions 2014-2019
Figure North America Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure North America Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table North America Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Europe Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Europe Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure China Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure China Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table China Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Japan Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Japan Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Southeast Asia Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure India Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure India Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table India Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Global Consumption Adalimumab Biosimilar Market Share by Application (2014-2019)
Figure Global Value (Consumption) Adalimumab Biosimilar Market Share by Application (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Sites and Area Served
Table AET BioTech Adalimumab Biosimilar Product Introduction, Application and Specification
Table AET BioTech Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Market Share (2014-2019)
Figure AET BioTech Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table AET BioTech Adalimumab Biosimilar Main Business and Markets Served
Table Amgen Adalimumab Biosimilar Production Sites and Area Served
Table Amgen Adalimumab Biosimilar Product Introduction, Application and Specification
Table Amgen Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Amgen Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Amgen Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Amgen Adalimumab Biosimilar Main Business and Markets Served
Table Boehringer Ingelheim Adalimumab Biosimilar Production Sites and Area Served
Table Boehringer Ingelheim Adalimumab Biosimilar Product Introduction, Application and Specification
Table Boehringer Ingelheim Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Main Business and Markets Served
Table Coherus Biosciences Adalimumab Biosimilar Production Sites and Area Served
Table Coherus Biosciences Adalimumab Biosimilar Product Introduction, Application and Specification
Table Coherus Biosciences Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Coherus Biosciences Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Main Business and Markets Served
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Sites and Area Served
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product Introduction, Application and Specification
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Main Business and Markets Served
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Sites and Area Served
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product Introduction, Application and Specification
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Market Share (2014-2019)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Main Business and Markets Served
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Sites and Area Served
Table Momenta Pharmaceuticals Adalimumab Biosimilar Product Introduction, Application and Specification
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Main Business and Markets Served
Table Oncobiologics Adalimumab Biosimilar Production Sites and Area Served
Table Oncobiologics Adalimumab Biosimilar Product Introduction, Application and Specification
Table Oncobiologics Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Oncobiologics Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Main Business and Markets Served
Table Pfizer Adalimumab Biosimilar Production Sites and Area Served
Table Pfizer Adalimumab Biosimilar Product Introduction, Application and Specification
Table Pfizer Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Pfizer Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Pfizer Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Pfizer Adalimumab Biosimilar Main Business and Markets Served
Table Samsung Bioepsis Adalimumab Biosimilar Production Sites and Area Served
Table Samsung Bioepsis Adalimumab Biosimilar Product Introduction, Application and Specification
Table Samsung Bioepsis Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Main Business and Markets Served
Table Sandoz Adalimumab Biosimilar Production Sites and Area Served
Table Zydus Cadila Adalimumab Biosimilar Production Sites and Area Served
Figure Global Adalimumab Biosimilar Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Adalimumab Biosimilar Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Adalimumab Biosimilar Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Adalimumab Biosimilar by Type (2019-2025)
Table Global Consumption (K Units) of Adalimumab Biosimilar by Application (2019-2025)
Table Adalimumab Biosimilar Distributors List
Table Adalimumab Biosimilar Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Japan Biosimilars- Landscape Today Outlook Tomorrow “Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinct - After a decade, JP Biosimilar guidelines’s first revision expected in FY2020 – Demonstrate Chuikyo need of biosimilar tool to curb healthcare cost- Biosimilars uptake varies as per each opportunity, Remicade BS vs. Rituxan BS – Two poles of the curve - A few skipping NHI listing due to manufacturing issues associated with constant supply need, ma
    Published: 06-Jan-2020        Price: US 4500 Onwards        Pages: 156
    Since 2009, 25 biosimilars of 12 originator products are approved in Japan and have yielded mixed performances and attained annual sales of ~¥32.4b ($300m). Unique biosimilars landscape with the entry of NESP “biosame” by originator Kyowa Hakko Kirin through its subsidiary, co-promotion/marketing collaboration with local companies for the front-end skill sets (Ayumi, Kyowa Hakko Kirin, Teijin) and few skipped listing to better manage constant supply (Pfizer), a key requirement......
  • 2020 Global Biosimilars Market Outlook
    Published: 31-Dec-2019        Price: US 2900 Onwards        Pages: 99
    The global Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China ......
  • Global Biologics and Biosimilars Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 30-Dec-2019        Price: US 2600 Onwards        Pages: 197
    In this report, we analyze the Biologics and Biosimilars industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also......
  • Global Adalimumab Biosimilar Market Data Survey Report 2015-2025
    Published: 28-Dec-2019        Price: US 1500 Onwards        Pages: 60
    Summary The global Adalimumab Biosimilar market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profil......
  • Biosimilars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Dec-2019        Price: US 3000 Onwards        Pages: 150
    Biosimilars Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilars industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilars manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Biosimilars market covering al......
  • 2017-2025 World Biologics and Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 15-Dec-2019        Price: US 2800 Onwards        Pages: 141
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • 2017-2025 World Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 15-Dec-2019        Price: US 2800 Onwards        Pages: 116
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes......
  • Global Adalimumab Biosimilar Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 12-Dec-2019        Price: US 3300 Onwards        Pages: 126
    Summary The report forecast global Adalimumab Biosimilar market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Adalimumab Biosimilar industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Adalimumab Biosimilar by geography. The report splits the market size, by volume......
  • Global Oncology Biosimilars Market Research (2015-2019) and Future Forecast (2020-2025)
    Published: 07-Dec-2019        Price: US 3300 Onwards        Pages: 119
    Summary The report forecast global Oncology Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Oncology Biosimilars industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncology Biosimilars by geography. The report splits the market size, by volume an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs